Clinical Activity of Sorafenib and Sunitinib in Renal Cell Carcinoma Refractory to Previous Vascular Endothelial Growth Factor–Targeted Therapy: Two Case Reports-Reference-Cited by-同舟云学术

Clinical Activity of Sorafenib and Sunitinib in Renal Cell Carcinoma Refractory to Previous Vascular Endothelial Growth Factor–Targeted Therapy: Two Case Reports

Published:2006-06 Issue:1 Volume:5 Page:78-81
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Shaheen Philip E.,Rini Brian I.,Bukowski Ronald M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference9 articles.

1. Mutations of the VHL tumour suppressor gene in renal carcinoma;Gnarra;Nat Genet,1994

2. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas;Na;J Urol,2003

3. The von Hippel-Lindau tumor suppressor gene and kidney cancer;Kaelin;Clin Cancer Res,2004

4. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma;Rini;J Clin Oncol,2005

5. Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC);Escudier;J Clin Oncol,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Drug Resistance Updates;2023-03

2. Three component synthesis of 2-oxindole via sequential Michael addition, intramolecular cyclization and aromatization;RSC Advances;2014

3. Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy;Journal of Medicinal Chemistry;2012-09-04

4. Second-line therapy for refractory renal-cell carcinoma;Critical Reviews in Oncology/Hematology;2012-07

5. Sequential use of targeted agents in the treatment of renal cell carcinoma;Critical Reviews in Oncology/Hematology;2011-01